Aging is not simply the passage of time; it is the progressive accumulation of cellular damage, stress responses and loss of regenerative capacity. To slow, measure or even reverse parts of aging, researchers first need to see it. That is why high-content screening (HCS) and benchtop automated microscopes — especially the Thermo Fisher Invitrogen EVOS platform — have become central to anti-aging and longevity research in UK labs. This article explains how imaging turns senescence biology into a quantitative drug-discovery workflow, and where the EVOS family fits.
Why aging biology needs imaging
The 2023 update to the Hallmarks of aging places cellular senescence, genomic instability, mitochondrial dysfunction and loss of proteostasis among the core drivers of aging. Each of these hallmarks produces visible, measurable changes inside cells:
- Senescence-associated β-galactosidase (SA-β-gal): the classic histochemical marker of lysosomal expansion in senescent cells, often imaged at pH 6.0.
- p16INK4a expression: a cyclin-dependent kinase inhibitor and key senescence biomarker, typically detected by immunofluorescence or reporter constructs.
- γH2AX foci: phosphorylated H2AX marks DNA double-strand breaks and accumulated genotoxic stress.
- Mitochondrial morphology: fragmented or swollen mitochondria reflect oxidative stress and metabolic dysfunction.
- Nuclear morphometrics: changes in nuclear area, shape, chromatin texture and nuclear speckles encode information about proliferative history and stress states.
Until recently, these markers were assessed manually or in low throughput. Modern automated microscopy makes it possible to score tens of thousands of cells per well, across hundreds of compounds, in multi-well plates — exactly the scale needed for anti-aging drug discovery.
What is high-content screening?
High-content screening combines automated fluorescence or brightfield imaging with multi-parametric image analysis. Instead of returning a single read-out, an HCS assay extracts hundreds of features per cell or per nucleus: intensity, size, shape, texture, spot counts, intensity ratios, and spatial relationships between markers.
For aging research, this is transformative. Senescence is heterogeneous: not all cells in a stressed population become senescent at the same time, and not all senescent cells express the same panel of markers. HCS captures that heterogeneity rather than averaging it away. It also lets researchers:
- Measure dose-response across many compounds in parallel
- Track multiple markers in the same cell
- Build morphology-based classifiers that predict functional states
- Link phenotypes to single-cell transcriptomics or metabolomics
In practice, an HCS workflow needs an automated imager, a stage that can visit every well reproducibly, software for autofocus and tiling, and an analysis pipeline that can segment cells and extract features. The EVOS M7000 and related platforms are designed precisely for this transition from manual microscopy to quantitative screening.
The EVOS family as an accessible automated imager
Thermo Fisher Invitrogen EVOS systems are widely used in UK universities, biotechs and core facilities because they offer automated imaging in a compact benchtop format. The range includes models for different throughput and budget levels, from the entry-level EVOS M3000 and M5000 for routine cell culture and fluorescence, through to the EVOS M7000 with automated stage, multi-well scanning, Z-stacking and live-cell incubation options.
For longevity labs, the relevant strengths are:
- LED fluorescence cubes for DAPI, GFP, RFP and far-red channels, covering the most common senescence and stress reporters
- Automated multi-well acquisition for 96- and 384-well senescence and senolytic screens
- Touch-driven and network-export software that lowers the barrier for biology-first users
- Onstage incubator compatibility for time-lapse observation of senescent cell dynamics
- Celleste image analysis for segmentation, object counting and morphometric reporting
A 2020 PLoS ONE methods paper described a complete high-throughput imaging and quantification pipeline built around the EVOS platform, demonstrating how open analysis tools can be integrated with the instrument for reproducible, large-scale cell biology (Klimaj et al., 2020). That kind of accessibility matters for UK longevity labs that may not have the capital or space for a full high-content analysis suite.
Specific aging applications: from senolytic screens to morphology classifiers
Senolytic and senomorphic screens
Senolytics selectively clear senescent cells; senomorphics suppress their damaging secretome without killing them. Both strategies require robust, scalable assays for senescence burden. A 2023 review in Aging Cell surveyed the practical strategies for senolytic drug discovery and highlighted the importance of imaging-based phenotypic assays alongside biochemical markers (Power et al., 2023).
More recently, a 2025 Communications Biology study reported an effective system for senescence-modulating drug development that combined quantitative high-content analysis with high-throughput screening. The workflow used multi-parameter imaging to score senescence modulation, demonstrating that HCS can accelerate the discovery of new senolytic and senomorphic compounds (Hu et al., 2025).
Rapamycin-responsive sub-populations
Rapamycin and mTOR modulation are among the best-studied interventions in aging biology, yet their effects are not uniform across all cells. A 2025 Aging Cell study used single-cell fluorescence imaging to reveal heterogeneity in senescence biomarkers and to identify rapamycin-responsive sub-populations. Rather than treating senescence as a single state, the imaging data showed distinct cellular clusters with different sensitivities to intervention (Seshadri et al., 2025). HCS is the natural platform to expand this approach to larger compound panels.
Single-cell morphology encodes senescence subtypes
A 2025 Science Advances paper showed that single-cell morphology alone can encode functional subtypes of senescence in aging human dermal fibroblasts. Using deep-learning analysis of brightfield and fluorescence images, the authors distinguished senescent sub-populations with different functional properties, without relying on a fixed panel of molecular markers (Kamat et al., 2025). This is a powerful argument for image-based HCS in aging research: the morphology is itself information.
Nuclear morphometrics and machine learning
Nuclear shape and chromatin organisation change with age, stress, and senescence. A 2025 Nature Communications study combined nuclear morphometrics with machine learning to identify dynamic states of senescence across age. The classifier separated cells into distinct senescence states based on nuclear features, linking morphology to molecular signatures (Sato et al., 2025). For labs already using EVOS or HCS platforms, adding nuclear morphometrics is a low-cost way to extract more biological insight from existing images.
Why this matters for UK research labs
Anti-aging research is moving from descriptive biology to intervention discovery. That shift demands reproducible, quantitative phenotyping at scale. A benchtop automated imager such as the EVOS M7000 lets a UK university lab or small biotech run pilot HCS assays — senescence scoring, senolytic screening, mitochondrial morphology profiling — without the footprint or service contract of a full high-content analysis suite.
The key is to match the biological question to the instrument and analysis pipeline. SA-β-gal and p16 immunofluorescence can be quantified with relatively simple segmentation. Morphometric classifiers and multi-marker panels demand better image analysis, often using Celleste, CellProfiler, or custom deep-learning workflows. Longitudinal live-cell assays need environmental control and stable focus. Plankton & Zoom covers these choices in our guides to fluorescence microscopes for UK labs and AI-powered cell counting with EVOS.
Longevity Tortoise: the wider longevity context
Imaging is only one layer of the anti-aging toolkit. For readers interested in the broader science of biological rejuvenation, our partner site Longevity Tortoise recently covered two complementary approaches:
- Partial reprogramming with Yamanaka factors and anti-aging peptides — how transient expression of reprogramming factors can reset aged cells without erasing identity.
- CMLase enzyme deglycation and age reversal — an enzymatic strategy for breaking advanced glycation end-products that accumulate with age.
Both fields rely on the same imaging read-outs — p16, SA-β-gal, γH2AX, mitochondrial health, nuclear morphology — to know whether an intervention is genuinely turning back cellular age. HCS and EVOS microscopes are the workhorses making that measurement possible.
References
- Klimaj SD, Licón-Muñoz Y, Kim J, et al. A high-throughput imaging and quantification pipeline for the EVOS imaging platform. PLoS ONE. 2020;15(8):e0236397. doi:10.1371/journal.pone.0236397 — https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0236397
- Hu Y, Xue X, et al. An effective system for senescence modulating drug development using quantitative high-content analysis and high-throughput screening. Communications Biology. 2025;8:935. doi:10.1038/s42003-025-08758-6 — https://doi.org/10.1038/s42003-025-08758-6
- Seshadri V, Chng C, et al. Single-Cell Fluorescence Imaging Reveals Heterogeneity in Senescence Biomarkers and Identifies Rapamycin-Responsive Sub-Populations. Aging Cell. 2025;24(9):e70007. PMC12507413 — https://pmc.ncbi.nlm.nih.gov/articles/PMC12507413/
- Kamat P, Macaluso NC, et al. Single-cell morphology encodes functional subtypes of senescence in aging human dermal fibroblasts. Science Advances. 2025;11(17):eads1875. doi:10.1126/sciadv.ads1875 — https://doi.org/10.1126/sciadv.ads1875
- Sato K, Eguchi T, et al. Nuclear morphometrics coupled with machine learning identifies dynamic states of senescence across age. Nature Communications. 2025;16:5552. doi:10.1038/s41467-025-60975-z — https://www.nature.com/articles/s41467-025-60975-z
- Power HT, Valtchev P, Dehghani F. Strategies for senolytic drug discovery. Aging Cell. 2023;22(9):e13889. PMC10577556 — https://pmc.ncbi.nlm.nih.gov/articles/PMC10577556/
- López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. Hallmarks of aging: An expanding universe. Cell. 2023;186(2):243-278. doi:10.1016/j.cell.2022.11.001 — https://doi.org/10.1016/j.cell.2022.11.001
Published 4 September 2026. Categories: Microscopy, High-Content Screening, Longevity, EVOS. Plankton & Zoom is an independent microscopy review site. For pricing, demonstrations, and service agreements, contact the manufacturer or an authorised UK distributor.